WellMedr

What you're buying

WellMedr sells compounded semaglutide and compounded tirzepatide as weekly injections, a brand-name lane alongside them, and a low-dose line it markets separately. The two main plans are simple: semaglutide for people who want the steadier option, tirzepatide for people who want the stronger one, both shipped to your door with unlimited clinician messaging included.

It names the parts of the chain most sites hide. Every GLP-1 product page states that prescriptions are "fulfilled and shipped by our licensed pharmacy partner: Mycelium Pharmacy" and adds that WellMedr does not dispense medication itself. The footer names OpenLoop Health as the clinical network and Wellmedr LLC as the company, and lists a phone number. A LegitScript certification is displayed. For a category where "a licensed U.S. pharmacy" is usually the whole answer, that is a meaningful amount of daylight.

Every plan also comes with what the company calls Care Coaching — you are paired with a certified medical assistant who checks in on consistency and dosing. It is included rather than sold as an upgrade.

What it costs (and how it's billed)

The two plan cards read "Starting At $49 a month" for semaglutide and "Starting At $89 a month" for tirzepatide, both under a heading that says Monthly Plan. Tirzepatide is sold at the same price regardless of dosage, printed on the card itself, so titrating up costs nothing extra. The brand lane is priced in the open too: Ozempic from $1,399 a month and Zepbound from $1,599 a month, both described as month-to-month.

Two things about those low figures matter more than the figures. First, they are floors, not rates. The banner running across the top of the site reads "Lock In $200 OFF Every Month, or $49/mo on 12/month Plans — For Life", which ties the cheaper number to a twelve-month commitment, while the card that displays it says Monthly Plan. No standing month-to-month price appears anywhere on the site, and both buttons hand off to a checkout that will not load without a plan already chosen.

Second, a month here is four weeks. Both cards say the medication ships every 4 weeks, which is thirteen shipments and thirteen charges in a year rather than twelve. That is roughly 8% more a year than the monthly label implies, and it is stated plainly enough — it is just never converted for you. A third figure at the foot of the page offers $150 off for life, which is a different promise from the $200 a month in the banner, and nothing explains how the two relate.

There is a money-back guarantee, set in capitals: no weight lost in 90 days and the company refunds everything. Cancellation is easy by the site's own account — manage, pause or cancel from the dashboard at any time.

Who can order

WellMedr does not publish the states it serves. Its own answers are asked the question directly and decline it: shipping goes "to all U.S. states where our services are available", which restates the question rather than answering it. Nowhere on the site is there a list, a map or an exclusion.

That is the row's weakest point, and it is weak in a specific way. A shopper in a state the clinical network does not cover has no way to find out except by starting an intake and reaching for a card. Everything else here is unusually well disclosed, which makes the silence stranger.

How the intake works

The intake is a quiz the site says takes three minutes, with no video visit required and no commitment before a clinician reviews it. If you are approved, the medication ships free and discreetly, and refills are timed to arrive before you run out. Same-day appointment availability and unlimited provider messaging are both advertised as included.

Support is by dashboard message, chat, email and a toll-free number. There is no published response-time standard, so "unlimited messaging" describes the volume and not the speed.

What we'd want changed

One answer on the site should be rewritten today. Asked "Are these medications FDA approved?", it replies: "Yes. We only work with U.S. licensed pharmacies that dispense FDA-approved medications." The pricing page on the same site says the opposite in its own safety notice — that compounded medications are overseen by state pharmacy regulators and are not evaluated by the FDA for safety or efficacy. A compounded GLP-1 is not an FDA-approved medication, and a customer reading only the answers page would come away believing it is.

The low-dose page needs the same treatment. It headlines "ZERO Side Effects" over a subhead reading "Zero side effct for 70%+ of members" — their typo, still there — and carries none of the thyroid or compounding warnings the pricing page carries. It also no longer publishes a price for any of its products, so the line that was once the cheapest way in is now the least legible.

Publish the states, publish a standing month-to-month rate beside the twelve-month one, and say out loud that thirteen four-week cycles fit in a year. And the before-and-after results scattered down the page are labeled "Inspired by real patient success stories in similar Telehealth programs" — which is an honest disclaimer attached to testimonials that are not this company's patients. Better to drop them than to footnote them.

Bottom line

WellMedr names its pharmacy, its clinical network, its legal entity and its certification, and prices both compounded molecules and both brand pens in public. Then it advertises a floor tied to a twelve-month lock as a Monthly Plan, bills every four weeks, tells you the medication is FDA approved when it is not, and will not say which states it covers. The good disclosure and the bad claims are on the same site, and you have to read both.